HomeSpecialitiesKidney Cancer Surgery

Robotic Surgery · Kidney Cancer

Robotic Kidney
Cancer Surgery

Minimally invasive robotic radical and benign nephrectomy — expert kidney surgery through small keyhole incisions, with most patients home within 1–2 days.

1–2
Nights Typical Hospital Stay
<2%
Major Complication Rate (Robotic)
4–6 wks
Return to Full Activity
95%+
5-Year Survival for Localised Disease
The Procedure

Robotic Radical & Benign Nephrectomy

Radical nephrectomy removes the entire kidney and is the treatment of choice for larger or complex renal tumours, centrally positioned cancers, and cases where complete removal is required to achieve clear oncological margins. It is also performed robotically, providing the same keyhole approach and rapid recovery.

Benign nephrectomy is the removal of a kidney for non-cancerous conditions — including chronic infection, obstruction causing a non-functioning kidney, severe pain, or other structural problems. These cases are managed with the same minimally invasive robotic technique.

Both operations are performed robotically through small port incisions, reducing blood loss, hospital stay and recovery time significantly compared to open surgery.

Every kidney case is different. My focus is on achieving the best oncological outcome — complete cancer control — whilst using the least invasive approach possible. Robotic surgery allows me to do this with greater precision, less blood loss and a faster recovery than open techniques.

— Mr Torath Ameen, FRCS (Urol)
Advantages of Robotic Surgery

Why Choose Robotic Nephrectomy?

Precision Tumour Removal

3D magnification and robotic instrument control allows precise tumour excision with clear margins, even in anatomically complex locations near the renal hilum.

Shorter Hospital Stay

Most patients are discharged 1–2 days after surgery versus 5–7 days for open nephrectomy.

Less Blood Loss

Robotic surgery is associated with significantly lower intraoperative blood loss and a far lower transfusion rate than open surgery.

Faster Recovery

Most patients return to normal activity within 4–6 weeks — compared to 6–12 weeks for open surgery.

Robotic Precision

The da Vinci robotic system provides magnified 3D vision and wristed instruments, enabling precise dissection and significantly reduced blood loss compared with open surgery.

Understanding Kidney Cancer

Types, Staging & When Surgery Is Needed

Most kidney cancers are discovered incidentally — found on a scan performed for an unrelated reason. This is why over 70% of kidney cancers in the UK are now diagnosed at an early, localised stage when cure rates are excellent.

Types of kidney cancer

Clear cell renal cell carcinoma (ccRCC) accounts for approximately 75% of kidney cancers. It arises from the cells lining the proximal tubule of the kidney. Surgery is the primary treatment for localised disease.

Papillary RCC (types 1 and 2) accounts for 10–15% of cases. Type 1 is generally less aggressive; type 2 can behave more aggressively and may be associated with hereditary leiomyomatosis and RCC syndrome.

Chromophobe RCC is the third most common subtype, with an excellent prognosis for localised disease.

Oncocytoma is a benign kidney tumour that can be indistinguishable from cancer on imaging. Biopsy is sometimes used to guide management when the radiological features are indeterminate.

Partial vs radical nephrectomy

Where technically feasible, nephron-sparing surgery (partial nephrectomy) — removing only the tumour and a margin of surrounding normal kidney — is preferred over complete kidney removal. This preserves renal function, which is particularly important in patients with diabetes, hypertension, a solitary kidney or pre-existing renal impairment.

Partial nephrectomy is recommended for all T1a tumours (under 4cm) and many T1b tumours (4–7cm) depending on position and anatomy. Mr Ameen performs robotic partial nephrectomy routinely, using intraoperative ultrasound to guide tumour excision while minimising ischaemia time (the period during which blood supply to the kidney is temporarily interrupted).

Radical nephrectomy — complete kidney removal — is reserved for larger or more complex tumours, those in an unfavourable central position, or where complete removal is required for adequate oncological clearance.

After Surgery

Recovery & Long-Term Follow-Up after Kidney Surgery

Hospital

Hospital Stay & Immediate Recovery

Most patients undergoing robotic nephrectomy spend 1–2 nights in hospital. Robotic partial nephrectomy patients typically go home on day 1–2. Drains are removed before discharge. Pain is managed with oral analgesics — the keyhole approach means post-operative pain is significantly less than with open surgery. Most patients are mobile and eating normally within hours of the procedure.

Return

Return to Normal Activity

Desk-based work from week 2–3. Driving from week 3–4, once comfortable with an emergency stop. Light exercise (walking, swimming) from week 4–6. Heavy lifting and strenuous activity from week 6–8. Most patients feel fully recovered within 6–8 weeks of surgery. The absence of large incisions means recovery is faster and more comfortable than traditional open kidney surgery.

Follow-up

Surveillance After Kidney Cancer Surgery

Imaging surveillance (CT or ultrasound depending on risk) is performed at 3–6 monthly intervals for the first 2 years, then annually for up to 5 years. Renal function blood tests are monitored regularly, particularly after radical nephrectomy. The majority of patients with localised kidney cancer treated surgically are cured. For higher-stage or higher-grade disease, additional systemic treatments may be discussed in a multidisciplinary setting.

Common Questions

Kidney Cancer Surgery FAQs

What is the difference between radical and benign nephrectomy?
This depends on the size, position and complexity of your tumour, as well as the function of both kidneys. Mr Ameen uses CT or MRI imaging and sometimes a nuclear medicine (DMSA) scan to assess each kidney's contribution to your overall kidney function. He will present both options to you at consultation and make a clear recommendation based on your individual anatomy and cancer characteristics.
What happens if my tumour is found to be benign after surgery?
Approximately 20–25% of kidney tumours removed surgically turn out to be benign (non-cancerous) on pathological analysis — most commonly oncocytomas or angiomyolipomas. While this is reassuring, surgery was still the right decision at the time based on the imaging characteristics. In selected cases, a biopsy before surgery may help avoid unnecessary operations, and Mr Ameen can discuss whether this applies to your situation.
Will I need chemotherapy or radiotherapy after kidney cancer surgery?
Unlike many other cancers, kidney cancer does not respond well to conventional chemotherapy or radiotherapy. For localised disease successfully removed surgically, no additional systemic treatment is needed. For higher-risk disease, adjuvant immunotherapy (pembrolizumab) is now NICE-approved in the UK. Mr Ameen works closely with oncology colleagues to coordinate this if required.
Can I live normally with one kidney?
Yes. Most people live full, healthy lives with a single kidney. The remaining kidney compensates over time, typically recovering to 70–75% of the combined function. You'll be advised to stay well hydrated, avoid NSAIDs (ibuprofen) long-term and have your kidney function checked annually. Life expectancy is not significantly reduced for people who lose one kidney from trauma or surgery.

Concerned about a kidney mass? Get expert advice.

Early assessment gives the best chance of kidney-preserving surgery. Mr Ameen offers rapid private consultations across Central London.

Book Online Now Call 0204 558 6750